Insulin Resistance Is Better Estimated by Using Fasting Glucose, Lipid Profile, and Body Fat Percent Than by HOMA-IR in Japanese Patients with Type 2 Diabetes and Impaired Glucose Tolerance: An Exploratory Study

被引:2
|
作者
Nakamura, Yui [1 ]
Otaki, Soichiro [1 ]
Tanaka, Yohei [1 ]
Adachi, Ayaka [1 ]
Wada, Nobuhiko [1 ]
Tajiri, Yuji [1 ,2 ]
机构
[1] Kurume Univ, Med Ctr, Diabet Ctr, Kurume, Japan
[2] Kurume Univ, Diabet Ctr, Med Ctr, Kurume 8390863, Japan
关键词
insulin resistance; steady state plasma glucose; glucose clearance; metabolic factor; anthropometric factor; HOMEOSTASIS MODEL ASSESSMENT; SENSITIVITY; INDEX; TRIGLYCERIDES; SECRETION; ACID;
D O I
10.1089/met.2023.0181
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: The aim of the present study is to estimate insulin resistance (IR) using clinically available parameters except for serum insulin or C-peptide concentration to overcome the limitation of homeostasis model assessment of IR (HOMA-IR), which has been widely used in clinical practice.Patients and Methods: Fifty-two admitted patients with type 2 diabetes or impaired glucose tolerance were enrolled, and steady state plasma glucose (SSPG) method and cookie meal tolerance test were performed together with fasting blood sampling and anthropometric measurements. Insulin sensitivity measured by SSPG was estimated as glucose clearance corrected by the excretion of glucose into urine (C-GC).Results: Log-transformed (C-GC) was negatively correlated with fasting plasma glucose (FPG), log (Fasting triglyceride: TG), log (Fasting TG/Fasting high-density lipoprotein cholesterol: HDLC), and their area under the curves (AUCs). Fasting and AUC-HDLC was positively and fasting free fatty acid (FFA) was negatively correlated with log (C-GC). Body fat (%) was negatively correlated with log (C-GC). Multiple regression analysis on log (C-GC) as an outcome variable revealed that FPG, log (AUC-TG/AUC-HDLC), body fat (%), and fasting FFA were selected as significant predictive variables and contributed to log (C-GC) by 60% (adjusted R2). Replacing log (AUC-TG/AUC-HDLC) with its fasting value, log (Fasting TG/Fasting HDLC), this model still showed a strong contribution to log (C-GC) by 57% (adjusted R2). These contributions were stronger than those in log (HOMA-IR) (52.5%), log (Fasting C-peptide) (45.7%) to log (C-GC).Conclusions: It is plausible that our estimation for IR without the inclusion of plasma insulin concentration can be applied in Japanese patients whose HOMA-IR is not appropriately available. The model using fasting values is less complicated and could be the best way for the estimation of IR.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 50 条
  • [31] GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects
    Fernandez-Garcia, Jose C.
    Murri, Mora
    Coin-Aragueez, Leticia
    Alcaide, Juan
    El Bekay, Rajaa
    Tinahones, Francisco J.
    CLINICAL ENDOCRINOLOGY, 2014, 80 (05) : 671 - 676
  • [32] Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study
    Harati, Hadi
    Hadaegh, Farzad
    Tohidi, Maryam
    Azizi, Fereidoun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 85 (01) : 90 - 95
  • [33] Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in an at-risk population:: data from the RIAD study using new diagnostic criteria
    Köhler, C
    Temelkova-Kurktschiev, T
    Schaper, F
    Fücker, K
    Hanefeld, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (37) : 1057 - 1061
  • [34] Effect of cilostazol on lipid, uric acid and glucose metabolism in patients with impaired glucose tolerance or type 2 diabetes mellitus - A double-blind, placebo-controlled study
    Toyota, T
    Oikawa, S
    Abe, R
    Sano, R
    Suzuki, N
    Hisamichi, S
    Fukao, A
    CLINICAL DRUG INVESTIGATION, 2001, 21 (05) : 325 - 335
  • [35] Effect of Cilostazol on Lipid, Uric Acid and Glucose Metabolism in Patients with Impaired Glucose Tolerance or Type 2 Diabetes MellitusA Double-Blind, Placebo-Controlled Study
    Takayoshi Toyota
    Shinichi Oikawa
    Ryuzo Abe
    Ryuichi Sano
    Norihiro Suzuki
    Shigeru Hisamichi
    Akira Fukao
    Clinical Drug Investigation, 2001, 21 : 325 - 335
  • [36] Role of adiponectin in relation to body mass index, insulin resistance, glucose-lipid metabolism and abdominal fat distribution in type 2 diabetic patients
    Terauchi, M
    Maruyama, H
    Hayashi, K
    Yamamoto, Y
    Nishikai, K
    Saruta, T
    DIABETES, 2002, 51 : A305 - A305
  • [37] Non-linear associations of cardiometabolic index with insulin resistance, impaired fasting glucose, and type 2 diabetes among US adults: a cross-sectional study
    Song, Jimei
    Li, Yimei
    Zhu, Junxia
    Liang, Jian
    Xue, Shan
    Zhu, Zhangzhi
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [38] Insulin secretion and insulin sensitivity in Japanese patients with type 2 diabetes: A cross-sectional study comparing the homeostasis model assessment-2 (HOMA2) indexes and indexes derived from the oral glucose tolerance test
    Yamamoto-Honda R.
    Osame K.
    Kitazato H.
    Shinkai-Goromaru M.
    Isogawa A.
    Yoshida Y.
    Kawazu S.
    Akanuma Y.
    Noda M.
    Diabetology International, 2011, 2 (2) : 72 - 78
  • [39] PREVALENCE OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS AND IMPAIRED GLUCOSE-TOLERANCE IN THE JAPANESE GENERAL-POPULATION - THE HISAYAMA STUDY
    OHMURA, T
    UEDA, K
    KIYOHARA, Y
    KATO, I
    IWAMOTO, H
    NAKAYAMA, K
    NOMIYAMA, K
    OHMORI, S
    YOSHITAKE, T
    SHINKAWU, A
    HASUO, Y
    FUJISHIMA, M
    DIABETOLOGIA, 1993, 36 (11) : 1198 - 1203
  • [40] In middle-aged siblings of patients with Type 2 diabetes mellitus normal glucose tolerance is associated with insulin resistance and with increased insulin secretion. The SPIDER study
    Pontiroli, AE
    Monti, LD
    Costa, S
    Sandoli, PE
    Pizzini, A
    Solerte, SB
    Mantovani, E
    Piatti, PM
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (05) : 681 - 686